HomeBMKDF • OTCMKTS
add
BioMark Diagnostics Inc
Previous close
$0.18
Year range
$0.14 - $0.24
Market cap
19.99M CAD
Avg Volume
1.06K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 41.54K | 12.62% |
Operating expense | 459.27K | 7.19% |
Net income | -406.76K | -3.32% |
Net profit margin | -979.13 | 8.26% |
Earnings per share | — | — |
EBITDA | -414.31K | -6.71% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 313.03K | 133.78% |
Total assets | 1.35M | 52.53% |
Total liabilities | 1.91M | 8.78% |
Total equity | -559.77K | — |
Shares outstanding | 90.89M | — |
Price to book | -18.39 | — |
Return on assets | -105.41% | — |
Return on capital | -131.55% | — |
Cash Flow
Net change in cash
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -406.76K | -3.32% |
Cash from operations | -506.43K | -227.80% |
Cash from investing | -2.20K | -190.37% |
Cash from financing | 653.22K | 410.54% |
Net change in cash | 144.59K | 629.49% |
Free cash flow | -391.67K | -2,257.45% |
About
Founded
2014
Headquarters
Website